Search Results for 'Elan'
8 results found.
Elan reports strong growth
Athlone-based pharmaceutical company Elan has reported an increase of 24 per cent in revenue over last year’s figures.
90 jobs to go in Athlone as Elan “realigns resources”
Up to 90 workers at Athlone’s Elan plant are to lose their jobs in the coming weeks.
First quarter losses for two healthcare giants despite sales increase
Two healthcare giants based in the midlands and the west have this week posted first quarter losses — despite a massive increase in sales in both companies.
Elan bags patent for Alzheimer’s treatment
Elan received a welcome boost this week as it was announced that the company had secured a key patent for its Alzheimer’s treatment.
Top Level Roofing and Cladding available for jobs with even small budgets
Top Level Roofing and Cladding was formed in 1999 by Thomas Lavin who has over 20 years’ experience in the industry working on numerous large-scale industrial projects including Intel, HP, Elan, Dell, Abbott, and Coca Cola, as well as supplying labour for various roofing and cladding sub-contractors. Kevin McCudden has a vast experience of over 20 years in surveying and project management for large scale construction projects through out Ireland and the UK, and he joined the company in 2005. Top Level Roofing and Cladding formed to act as a supply and fit C2 registered sub-contractor in the construction industry. The company has assembled a team of professionals with extensive knowledge in the management of projects and the installation of roofing and cladding materials.
Elan strikes $1.5 bn deal with Johnson & Johnson
Athlone-based company Elan is to receive an injection of $1.5 billion from drug company Johnson & Johnson, as part of a deal to expand Elan’s research into the treatment of Alzheimer’s.
More upheaval for Elan after summons to appear in US Federal Court
The Monksland-based phamaceutical firm Elan has been summoned to appear in a Federal court in the US after disclosing two cases of a brain disorder related to its trump product, prior to a €605m ($885m) share sale earlier this month.
Elan’s Tysabri lowers Crohn’s hospitalisations
Athlone-based pharmaceutical company, Elan, and its US partner Biogen have announced that their drug Tysabri has been proven to significantly reduce the rate of hospitalisation of patients with moderate-to-severe Crohn’s disease.